These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11326)

  • 1. The occurrence of two polymorphs of D-penicillamine.
    Vidler JA
    J Pharm Pharmacol; 1976 Aug; 28(8):663. PubMed ID: 11326
    [No Abstract]   [Full Text] [Related]  

  • 2. X-ray structural studies and physicochemical characterization of (E)-6-(3,4-dimethoxyphenyl)-1-ethyl-4-mesitylimino-3-methyl- 3,4-dihydro-2(1H)-pyrimidinone polymorphs.
    Miyamae A; Kitamura S; Tada T; Koda S; Yasuda T
    J Pharm Sci; 1991 Oct; 80(10):995-1000. PubMed ID: 1784011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physico-chemical properties of muroctasin.
    Moroi R; Yamazaki K; Hirota T; Watanabe S; Kataoka K; Ichinose M
    Arzneimittelforschung; 1988 Jul; 38(7A):953-9. PubMed ID: 3190802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical characterization of the hydrates of urapidil.
    Botha SA; Caira MR; Guillory JK; Lötter AP
    J Pharm Sci; 1988 May; 77(5):444-51. PubMed ID: 3411469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational study of two polymorphs of spiperone: possible consequences on the interpretation of pharmacological activity.
    Azibi M; Draguet-Brughmans M; Bouche R; Tinant B; Germain G; Declercq JP; Van Meerssche M
    J Pharm Sci; 1983 Mar; 72(3):232-5. PubMed ID: 6842373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism of phenylbutazone: properties and compressional behavior of crystals.
    Ibrahim HG; Pisano F; Bruno A
    J Pharm Sci; 1977 May; 66(5):669-73. PubMed ID: 874748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anomalous behaviour of some oxyclozanide polymorphs.
    Pearson JT; Varney G
    J Pharm Pharmacol; 1973 Dec; 25():Suppl:62P-70P. PubMed ID: 4150594
    [No Abstract]   [Full Text] [Related]  

  • 8. Model for the binding of D-penicillamine to metal ions in living systems: Synthesis and structure of L-histidinyl-D-penicillaminatocobalt(III) monohydrate, [Co(L-His)(D-Pen)]-H2O.
    de Meester P; Hodgson DJ
    J Am Chem Soc; 1977 Jan; 99(1):101-4. PubMed ID: 830674
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of polymorphs and solvates of 3-amino-1-(m-trifluoromethylphenyl)-6-methyl-1H-pyridazin-4-one.
    Chauvet A; Masse J; Ribet JP; Bigg D; Autin JM; Maurel JL; Patoiseau JF; Jaud J
    J Pharm Sci; 1992 Aug; 81(8):836-41. PubMed ID: 1357154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a new crystalline synthetic gastric antacid, almagate.
    Moragues J; Beneyto JE; Fábregas JL; Spickett RG
    Arzneimittelforschung; 1984; 34(10A):1346-9. PubMed ID: 6548918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectroscopic and catalytic properties of penicillamine-molybdenum complexes.
    Sugiura Y; Kikuchi T; Tanaka H
    Chem Pharm Bull (Tokyo); 1977 Feb; 25(2):345-9. PubMed ID: 192478
    [No Abstract]   [Full Text] [Related]  

  • 12. Physicochemical characterizations of piroxicam-poloxamer solid dispersion.
    Shin SC; Cho CW
    Pharm Dev Technol; 1997 Nov; 2(4):403-7. PubMed ID: 9552469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interaction between macromolecular adjuvants and drugs. 24. Improvement of the solubility characteristics of benzodiazepine derivatives with polyvinylpyrrolidone].
    Keipert S; Voigt R
    Pharmazie; 1986 Jun; 41(6):400-4. PubMed ID: 2876444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal modification of methisazone by grinding.
    Lee KC; Hersey JA
    J Pharm Pharmacol; 1977 Apr; 29(4):249-50. PubMed ID: 17681
    [No Abstract]   [Full Text] [Related]  

  • 15. Physico-chemical properties and stabilities of the highly potent calcium antagonist benidipine hydrochloride.
    Suzuki H; Ono E; Ueno H; Takemoto Y; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1671-6. PubMed ID: 3219139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of dissolution characteristics of psoralen by cyclodextrins complexation.
    Vincieri FF; Mazzi G; Mulinacci N; Bambagiotti-Alberti M; Dall' Acqua F; Vedaldi D
    Farmaco; 1995; 50(7-8):543-7. PubMed ID: 7669193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I.
    Grzesiak AL; Lang M; Kim K; Matzger AJ
    J Pharm Sci; 2003 Nov; 92(11):2260-71. PubMed ID: 14603511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the reactions of D- and L-penicillamine with some aldimines of pyridoxal phosphate].
    Hasenbank G; Körber F; Siegmund P
    Hoppe Seylers Z Physiol Chem; 1968 Mar; 349(3):310-6. PubMed ID: 5725541
    [No Abstract]   [Full Text] [Related]  

  • 19. [The action of penicillamine antipodes on aspartate transaminase and the reaction of the pyridoxal phosphate thiazolidines (3-hydroxy-2-methyl-5-phosphono-oxymethyl-4-(5,5-dimethyl-4-carboxy-thiazolidinyl-(2))-pyridine) derivatives of 1-and D-penicillamine with apo-aspartate transaminase].
    Siegmund P; Hasenbank G; Körber F
    Hoppe Seylers Z Physiol Chem; 1968 Aug; 349(8):1062-70. PubMed ID: 5736308
    [No Abstract]   [Full Text] [Related]  

  • 20. Structural components of alginic acid. II. The crystalline structure of poly-alpha-L-guluronic acid. Results of x-ray diffraction and polarized infrared studies.
    Atkins ED; Nieduszynski IA; Mackie W; Parker KD; Smolko EE
    Biopolymers; 1973; 12(8):1879-87. PubMed ID: 4733713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.